Cite
Gocho Y, Liu J, Hu J, et al. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. Nat Cancer. 2021;2(3):284-299doi: 10.1038/s43018-020-00167-4.
Gocho, Y., Liu, J., Hu, J., Yang, W., Dharia, N. V., Zhang, J., Shi, H., Du, G., John, A., Lin, T. N., Hunt, J., Huang, X., Rowland, L., Shi, L., Maxwell, D., Smart, B., Crews, K., Yang, W., Hagiwara, K., Zhang, Y., Roberts, K., Wang, H., Jabbour, E., Stock, W., Eisfelder, B., Paietta, E., Newman, S., Roti, G., Litzow, M., Zhang, J., Peng, J., Chi, H., Pounds, S., Relling, M. V., Inaba, H., Zhu, X., Kornblau, S., Pui, C. H., Konopleva, M., Teachey, D., Mullighan, C. G., Stegmaier, K., Evans, W. E., Yu, J., & Yang, J. J. (2021). Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. Nature cancer, 2(3), 284-299. https://doi.org/10.1038/s43018-020-00167-4
Gocho, Yoshihiro, et al. "Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia." Nature cancer vol. 2,3 (2021): 284-299. doi: https://doi.org/10.1038/s43018-020-00167-4
Gocho Y, Liu J, Hu J, Yang W, Dharia NV, Zhang J, Shi H, Du G, John A, Lin TN, Hunt J, Huang X, Rowland L, Shi L, Maxwell D, Smart B, Crews K, Yang W, Hagiwara K, Zhang Y, Roberts K, Wang H, Jabbour E, Stock W, Eisfelder B, Paietta E, Newman S, Roti G, Litzow M, Zhang J, Peng J, Chi H, Pounds S, Relling MV, Inaba H, Zhu X, Kornblau S, Pui CH, Konopleva M, Teachey D, Mullighan CG, Stegmaier K, Evans WE, Yu J, Yang JJ. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. Nat Cancer. 2021 Mar;2(3):284-299. doi: 10.1038/s43018-020-00167-4. Epub 2021 Jan 21. PMID: 34151288; PMCID: PMC8208590.
Copy
Download .nbib